CN106418015A - 一种清调食补饮品的配方和制备方法 - Google Patents
一种清调食补饮品的配方和制备方法 Download PDFInfo
- Publication number
- CN106418015A CN106418015A CN201510514665.9A CN201510514665A CN106418015A CN 106418015 A CN106418015 A CN 106418015A CN 201510514665 A CN201510514665 A CN 201510514665A CN 106418015 A CN106418015 A CN 106418015A
- Authority
- CN
- China
- Prior art keywords
- days
- defecation
- day
- normal
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 14
- 235000005911 diet Nutrition 0.000 title abstract description 7
- 230000006870 function Effects 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title abstract description 5
- 230000000378 dietary effect Effects 0.000 title abstract description 3
- 230000001105 regulatory effect Effects 0.000 title abstract description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 10
- 235000009566 rice Nutrition 0.000 claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 claims abstract 2
- 210000000582 semen Anatomy 0.000 claims description 38
- 235000011194 food seasoning agent Nutrition 0.000 claims description 12
- 230000000694 effects Effects 0.000 abstract description 13
- 210000002784 stomach Anatomy 0.000 abstract description 11
- 230000036541 health Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 8
- 210000000936 intestine Anatomy 0.000 abstract description 8
- 230000037213 diet Effects 0.000 abstract description 4
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 230000005784 autoimmunity Effects 0.000 abstract description 3
- 240000008042 Zea mays Species 0.000 abstract description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 235000005822 corn Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000068988 Glycine max Species 0.000 abstract 1
- 235000010469 Glycine max Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 240000001417 Vigna umbellata Species 0.000 abstract 1
- 235000011453 Vigna umbellata Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 230000013872 defecation Effects 0.000 description 97
- 206010010774 Constipation Diseases 0.000 description 23
- 238000000465 moulding Methods 0.000 description 20
- 230000007958 sleep Effects 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 15
- 230000036528 appetite Effects 0.000 description 14
- 235000019789 appetite Nutrition 0.000 description 14
- 241000209094 Oryza Species 0.000 description 8
- 208000005171 Dysmenorrhea Diseases 0.000 description 7
- 206010013935 Dysmenorrhoea Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000003340 mental effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000037396 body weight Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000001976 improved effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 201000009053 Neurodermatitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 229930182493 triterpene saponin Natural products 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NYRXUBDGDSRBGB-UHFFFAOYSA-N Obtusifolin Chemical compound O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(C)C(O)=C2OC NYRXUBDGDSRBGB-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 239000000799 cathartic agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 101100463469 Caenorhabditis elegans lin-42 gene Proteins 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- SBVZTBIAKFTNIJ-CZNQJBLBSA-N Cassiaside Chemical compound C1=CC=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SBVZTBIAKFTNIJ-CZNQJBLBSA-N 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016352 Feeling of relaxation Diseases 0.000 description 1
- 208000002639 Fissured Tongue Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- ZCHGCYXNSBHAEG-UHFFFAOYSA-N Obtusifolin Natural products COc1ccc2C=C(C(=O)Oc2c1C=CC(=C)C)C(C)(C)C=C ZCHGCYXNSBHAEG-UHFFFAOYSA-N 0.000 description 1
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 1
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 1
- KSIVGTKSVYIZEB-GDUJLLAZSA-N Ophiopogonin A Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1O[C@@H]1C[C@H](O)CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](OC(C)=O)[C@H]1O KSIVGTKSVYIZEB-GDUJLLAZSA-N 0.000 description 1
- HGHDGOQXDUNVGT-UHFFFAOYSA-N Ophiopogonin B Natural products CC1CCC2(OC1)OC3CC4C5CC=C6CCCC(OC7OC(C)C(O)C(O)C7OC8OC(C)C(O)C(O)C8O)C6(C)C5CCC4(C)C3C2C HGHDGOQXDUNVGT-UHFFFAOYSA-N 0.000 description 1
- OWGURJWJHWYCIQ-AKYREZHBSA-N Ophiopogonin B Chemical compound O([C@@H]1[C@@H](O)[C@@H](O)[C@@H](C)O[C@H]1O[C@@H]1C[C@H](O)CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@]21C)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O OWGURJWJHWYCIQ-AKYREZHBSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 206010033971 Paratyphoid fever Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010035630 Plicated tongue Diseases 0.000 description 1
- 206010051986 Pneumatosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001518 anti-nephritic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- OXLQCHMJDJSJKF-UHFFFAOYSA-N cassiaside Natural products C1=C(O)C=C2C=C3OC(C)=CC(=O)C3=C(O)C2=C1OC1OC(CO)C(O)C(O)C1O OXLQCHMJDJSJKF-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- -1 flavone compounds Chemical class 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- KSIVGTKSVYIZEB-UHFFFAOYSA-N lirioplioside B Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C45C)C)C1CC2C3CC=C4CC(O)CC5OC1OC(C)C(O)C(O)C1OC1OC(C)C(O)C(OC(C)=O)C1O KSIVGTKSVYIZEB-UHFFFAOYSA-N 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000003238 somatosensory effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种清调食补饮品的配方及制备方法,包括藏红花、西洋参、枸杞、麦冬、陈皮、甘草、决明子、大枣、黄豆、红小豆、江米、薏米仁,玉米,本发明的有益效果是,用药合理,配方科学,患者不需节食,即可达到养生排毒、调理肠胃功能、增强体质和自身免疫力的目的,无毒副作用,安全健康,治疗方便。
Description
技术领域
本发明主要涉及中医保健领域,尤其涉及一种清调食补饮品配方及制备方法。
背景技术
随着生活水平的不断提高,生活节奏的不断加快,人们的生活习惯发生很大改变,饮食无常,过度安逸,饱食终日,疏于锻炼,饮食结构不合理;许多人患大病、久病之后失于调理、女性经、孕、产、乳期耗伤精血等,种种因素导致现代人出现面部痤疮,面色萎黄,肌肤不泽,腹胀便秘,黄褐斑,肥胖病症等。
故而调整机体阴阳,补益脏腑气血,排出体内毒素,升清降浊是治疗之本。目前市场上虽然也有一些调理食补的汤剂或药物,但其主要是利用大黄和泄叶来促进排出宿便,长期饮用会产生依赖性,并对人体造成一定危害。
本发明,继承了前人经验的基础上,经过二十多年的反复实践,最终破解了难题,提供了一种清调食补汤剂配方及制备方法,达到了不用节食即可养生排毒、调理肠胃功能、增强体质和自身免疫力的目的。
发明内容
本发明提出一种清调食补饮品的配方及制备方法,解决现有状况中存在的问题。
清调食补汤剂配方,特征为:藏红花8-12枚、西洋参3-8g、枸杞5-10g、麦冬5-15g、陈皮3-8g、甘草3-8g、决明子5-10g、大枣5-10g、黄豆5-15g、红小豆5-10g、江米5-10g、薏米仁5-10g,黑米8-15g、玉米8-15g。
本发明清调食补饮品的配方中:
藏红花:主要含胡萝卜素和苦味素,系其药理活性物质。还含挥发油成分。胡萝卜色素为西红花的主要色素,含量约2%,主要系西红花苷元与各种糖所组成的各种糖苷。苦味素主要为西红花苦素。药理试验证明,本品有兴奋子宫、活血与止血、抗肾炎、抗动脉粥样硬化、抗癌、抗自由基氧化、促进视网膜动脉血流量等作用。
西洋参:主要含三萜皂苷,以人参皂苷Rb1的含量最高,具有以奥克梯醇为苷元的特征性成分假人参皂苷F11。西洋参及人参皂苷Rb1对大脑皮层有镇静安定和中枢抑制作用;煎剂静脉注射能抗免心律失常;皂苷静脉注射可抗兔心肌缺血;抑制血小板聚集和降低血液凝固性。
枸杞:含多糖、脂肪酸、甜菜碱、胡萝卜素、核黄素、烟酸、氨基酸、维生素C及多种微量元素等。具有抗脂肪肝、抗衰老、提高免疫力等作用。
麦冬:含多种甾体皂苷,其中麦冬皂苷A含量最高,麦冬皂苷B次之;此外含多种高异黄酮类化合物。从麦冬中还分离鉴定出5种黄酮类化合物。实验还证明,麦冬中的水溶性多糖有抗缺氧和免疫促进作用,麦冬有明显提高耐缺氧能力、增强免疫功能、降低血糖等药理作用。麦冬为良好的养阴润肺药,近年来发现其在降低血糖的作用较好;临床应用强心作用稳定而效果佳。
陈皮:含挥发油能促进唾液、胃液等消化液分泌和消除肠内积气。
甘草:含三萜皂苷、黄酮、香豆素等。甘草有肾上腺皮质激素作用,抗炎、抗过敏反应,抗癌,抗菌,抗病毒,防止动脉硬化,抗脑缺血,预防糖尿病并发症等作用。
决明子:含游离羟基蒽醌衍生物,为大黄酚、大黄素、大黄素甲醚、决明素、钝叶素、决明苷、钝新素等多种成分。可用HPLC法测定其大黄酚或决明子苷A的含量。其水浸液有降压、利尿作用,并有缓泻、收缩子宫作用;其醇浸出液对葡萄球菌及白喉、巨大芽孢、伤寒、副伤寒、乙型副伤寒、大肠等杆菌均有抑制作用;其水浸剂对多种致病性皮肤真菌均有抑制作用,并有降血脂的作用。
大枣:用治脾虚食少、气血津液不足、乏力便溏、妇人脏燥。具有增强体力、抗疲劳、镇静安神、保肝、增加白细胞CAMP、增强免疫和抗变态反应等功能。
大豆:透邪解表,利湿解热。属解表药下属分类的辛凉解表药。
红小豆:含有糖类、三萜皂苷。20%赤小豆煎剂对金黄色葡萄球菌、福氏痢疾杆菌等有抑制作用。利水消肿、解毒排脓。属利水渗湿药下属中的利水消肿药,赤小豆具有增强细胞免疫、避孕等作用。
江米是一种温和的滋补品,有补虚、补血、健脾暖胃、止汗等作用。适用于脾胃虚寒所致的反胃、食欲减少、泄泻和气虚引起的汗虚、气短无力、妊娠腹坠胀等症。现代科学研究表明,江米含有蛋白质、脂肪、糖类、钙、磷、铁、维生素B及淀粉等,为温补强壮品。
薏米仁:健脾,渗湿,止泻,排脓,活血祛瘀,润肠,通便,润肺,化痰,消痈,利水,补脾,祛湿,对痘痘有一定的作用,也可以治疗水肿。
黑米:含蛋白质、碳水化合物、B族维生素、维生素 E、钙、磷、钾、镁、 铁、锌等营养元素,营养丰富;具有清除自由基、改善缺铁性贫血、抗应激反应以及免疫调节等多种生理功能;黑米中的黄铜类化合物能维持血管正常渗透压,减轻血管脆性,防止血管破裂和止血;黑米有抗菌,降低血压、抑制癌细胞生长的功效;还具有改善心肌营养,降低心肌耗氧量等功效。
玉米:每100克玉米含热量106千卡,纤维素2.9克,蛋白质4.0克,脂肪1.2克,碳水化合物22.8克,另含矿物质元素和维生素等。玉米中含有的粗纤维,比精米、精面高4-10倍。玉米中还含有大量镁,镁可加强肠壁蠕动,促进机体废物的排泄。
本发明有益效果独特之处为:
1、用药合理,配方科学,患者不需节食,即可达到养生排毒、调理肠胃功能、增强体质和自身免疫力的目的。
2、本发明提供的清调食补饮品无毒副作用,安全健康,治疗方便。
3、本品用量为每日0.5升,早晚分两次加热服用。
具体实施方式及制备方法如下:
本发明提供了一种清调食补饮品的配方,
包括藏红花8-12枚、西洋参3-8g、枸杞5-10g、麦冬5-10g、陈皮3-8g、甘草3-8g、决明子5-10g、大枣5-10g、黄豆5-15g、红小豆5-10g、、江米5-10g、薏米仁5-10g、黑米8-15g、玉米8-15g。
优选用量:所述藏红花为10枚,所述西洋参为5g,所述枸杞为8g,所述麦东为8g,所述陈皮为5g、所述甘草为5g、所述决明子为8g、所述大枣8g、所述黄豆为10g、所述红小豆为8g、所述江米为8g、所述薏米仁为8g、所述黑米10g,所述玉米10g。
本发明还提供了上述清调食补汤剂配方的制备方法,包括以下步骤:
S1:所述大豆、所述红小豆、所述玉米浸泡4小时以上,所述薏米仁浸泡8小时以上;所述黑米浸泡12小时以上;所述江米浸泡2小时以上;
S2:将S1中浸泡好的所述黑米、所述薏米仁、所述大豆、所述红小豆、所述江米、所述玉米以及所述大枣,放入4升矿泉水A中用武火烧开,15分钟后至文火,熬制后过滤为1升汤汁A,备用;
S3:所述藏红花、所述枸杞、所述麦冬、所述陈皮、所述甘草、所述决明子用清水洗净,浸泡1小时后,加入3.5升矿泉水B到砂锅中,所述西洋参用矿泉水浸泡1.5小时,待砂锅熬制到1.5升后将西洋参放入砂锅内,熬制后过滤为1升汤汁B,备用;
S4:将S2中的所述汤汁A与S3中的所述的汤汁B混合放入洗干净的砂锅内,文火熬制成1升汤剂即成。
作为上述清调食补汤剂配方的制备方法的优选,
在所述步骤S2中,所述清水A为4升,所述汤汁A为1升;
在所述S3中,所述清水B为3.5升,所述汤汁B为1升(西洋参后放);
在所述步骤S4中,所述汤剂为1升。
本发明经实际应用,列举典型病例如下:
20人一组,早上空腹喝一次250ML,晚上饭后一小时喝一次250ML。
一、其中女士15人,男士5人;年龄15-25岁,6名;26-35岁,1名;36-45岁,4名;46-55岁,2名;56-65岁,6名;66岁以上,1名。
二、实际使用方法:
10天为一周期,应连续服用3周期,每日早上空腹喝本饮品250毫升,晚饭后一小时喝250毫升。
三、评定方法:
1.症状:每个使用本品的人,都有不同程度的便秘,脸色灰暗,皮肤无光泽,精神不振,肥胖,女性有痛经,月经不调的症状。
2.使用标准:经过3个周期的服用:排便正常,失眠改善,精神好转,脸色皮肤有光泽,增强食欲,体重减轻,女性痛经消失,说明本品对机体调整是成功的。若无改善则为失败。
3.实际使用结果:全部20例,成功20例,失败0例,有调节效果率为100%。
具体实例如下:
1、江小姐,18岁,女,加拿大华裔,留学生,症状:便秘,虚弱,肥胖。
第1天服后能感觉到肠胃蠕动,第2天排便成型,第3天排便增加,4-5天感觉到有食欲,6-7-8天,每天排便两次,第8-9天,感觉身体轻松,排便正常,第10-15天,排便正常,回国后,食欲增加,身体有力气,皮肤变白,身体感觉轻松很多,腰部瘦了,腹部减小,体重减轻。
2、李小姐,19岁,女,症状:体虚,便秘,微胖。
第1天没反应,第2天没反应,第3天排便一次,第4-5天各排便一次,第6-7天各排便两次,第8-9天,各排便两次,第10-12天,回复正常排便,食欲增加,精神状态转好。一个半月后,瘦了8斤,皮肤有光泽,5年后一直保持体重,并未反弹。
3、王小姐,21岁女孩,症状:痛经,便秘,脸色灰暗。
第1天反应肚胀,第2天排便一次,第3天正常排便脸色有所改变,第4-10天每天正常排便,或排便两次,第11-15天排便两到四次,(增加药量三分之一),第16天后停服,每天正常排便,一个星期后继续服用2个星期,期间每天排便2-3次,成型,皮肤有光亮,每月的痛经好了,后又连续服用一个星期,脸色红润有光泽。
4、赵小姐,27岁女孩,症状:便秘,痛经。
第1天没反应,第2-4天正常排便,成型,第5-7天排便2次,精神气足,手脚冰凉的症状改善,睡眠好。第8-12天,正常排便,规律,成型,后连续服用一个月后痛经完全好了,皮肤有光泽,排便正常。
5、冯小姐,25岁,女孩,症状:消瘦,皮肤暗黄,痛经。
第1天没反应,第2天没反应,第3天排便一次稀少成型,第4-5正常排便一次,第6-10天正常排便一次,第11-13天,排便两次,第14-16天排便2次,第17-20天每日排便1到2次,第21-25天正常排便,成型,第26-30天正常排便1到2次,一个月半后,痛经好了,睡眠好,有力气精神好,皮肤有光泽,食欲增加。
6、张女士,39岁,女,症状:便秘,脸色发黑暗,裂纹舌,神经性皮炎,白天精神萎靡,夜晚失眠。
第1天没反应,第2天排便稀少,陈便发黑,第3天排便2次,一次清晨,一次下午4点,土黄色,成型,粘腻,第4-5天排便正常有时一天2次,成型,颜色发黑,第6-9天,每天排便2次,颜色发黑,成型,顺畅,晚上睡眠好转,第10-13天,排便1次,睡眠特好,神经性皮炎有好转的迹象,第14-18天排便正常,成型,量大,食欲好,第19-22天,每天排便2次,黄色,午后不犯困了,精神气好多了,脸上皮肤有光泽,第23-26天,排便正常,有时是黑色,成型, 睡眠好,一个月后,精神起色好多了,睡眠有很大改善,神经性皮炎得到改善,排便有规律,舌苔好多了。
7、王女士,48岁,女,职业医生,脾胃不和,睡眠不实,肾虚,肝郁气滞
第1天没反应,第2-3天排便一次,第4-8天每天排便2次,第8-15天,每天正常排便,食欲好,睡眠改善。
一个月后,停药,3个月后,又喝了半个月,半年后,排便正常,睡眠好,脸上的斑点变暗,精神状态明显好转。
8、马女士,女,56岁,便秘,一直吃麻仁胶囊,
第1天,没反应,第2-5天排便正常,有时一天2次,第6-8天排便正常,
第9-10天,排便正常,以后停喝,排便正常,成型。无反弹。
9、胡女士,女,57岁,偏胖,浮肿,睡眠不好,132斤。
第1天没反应,第2天,正常排便,睡眠改善,第3-5天正常排便,通畅,成型,第6-9天,排便正常,皮肤明显有光泽,睡眠很好,15天后,每天正常排便,成型,精神状态特好,一个月后,体重减轻6斤。
10、张女士,58岁,女,症状:便秘,腹胀,恶心,软便,很少排气
第1天没反应,第2天排便1次,多次排气,第3天,腹中没有胀气现象,没有不良反应,第4-6天排便1次,软便成型,偶尔排气,食欲增加,第7-14天正常排便,成型,无腹胀感,第15天以后一切正常。
11、刘女士,65岁,女,症状:便秘,高血压患者。
第1天没反应,第2-3天排便两次,第4-6天,排便两次,7-15天排便正常,精神状态改善明显,睡眠好,一个月后血压趋于正常。
12、廖女士,75岁,女,症状:长期严重便秘,一直喝清肠茶,有时还要加黑豆茸等泻药,才能排便。
第1天没反应,第2天排便一次量少,较通畅,第3-5天无排便,第6天正常排便,成型,第7天停药一天,第8-10天,排便正常,且排便量大。她的肠胃吸收功能已经被其它泻药损伤严重,效果不明显。但她自己感觉肠胃通畅很多,有时排气,精神见好,睡眠好。
13、李先生,38岁,男,症状:便秘,胖,睡眠不好,肾亏,无力盗汗,不能干重活。
第1天没反应,第2-3天排便2次,第4-6天正常排便,食欲好,第7-10天失眠好转,正常排便,第11-15天,正常排便,精神状态好转,感觉有力气。
14、王先生,61岁,男,症状:胖,肾亏,便秘。
第1天没反应,第2-5天排便两次,第6-8天正常排便,第9-15天正常排便,食欲好,16-30天,正常排便,睡眠好,一个月后,身体状态明显好转,有力气,45天后,减了8斤体重,
15、吴先生,40岁,男,症状:啤酒肚,肥胖。
第1天没反应,第2天没喝,第3天-第30天,隔一天喝一次,精神状态好转,有时一天排便2次,食欲好,睡眠好,啤酒肚明显减小,体重降了18斤。
16、郭先生60岁,男,症状:体胖,肾亏,便秘。
第1天没反应,第2-5天正常排便一次,第6-8天每天排便2次,第9-15天每天正常排便一次,睡眠好转,第16-20天精神状态明显好转,第21-30天,正常排便,食欲好,体重感觉减轻,第30-40天,正常排便,体重减去10斤,三个月后,体重减去20斤,睡眠好,身体有劲。
17、林先生42岁,男,稍胖,体虚,便秘,失眠等,
第一天,没反应,第2-4天排便量增大,第5-8天每天排便2次,第9-12天正常排便,睡眠好转,第13-15天,腹部感觉轻松,有精神,一个月后,腰围减少3CM,体重减少4斤,感觉精神好,深度睡眠好,便秘消失。
18、董女士,女,54岁,多年便秘,导致视网膜破裂,四五天排一次便。
第1天,无反应,第2天,下午排便,第3天,正常排便,第4-6天,正常排便,10日后,排便正常,无反弹。
19、刘小姐,女,24岁,便秘,脸色暗黄,排便时间不规律,服用过酚酞含片。
第1-2天无反应,第3-5天没服药,排便一次,第6-8天服用后,只排便一次,第9-10天,各排便一次,量不多,第11-14天,正常排便,发干,第15-18 天正常排便,有时一天2次,较顺畅,第19-23日,正常排便,第24-30日,正常排便,便秘情况基本没有了。
20、余小姐,女,22岁,脸色灰暗,无光泽,之前喝了3个月有泄肠功能的中药,停后,便秘,上学期间,也用了泻药,也有便秘的问题。
第1天,没有反应,第2天,有便意,排便顺畅,成型,第2天,中午后排便,量少,脸色变好,第3天,没排便,腹胀,食欲差,第4-6天,排便正常,成型,第7-10天,排便正常,有时有腹胀的感觉,脸色有好转,有光泽,第11-15天排便正常,成型,今后没有便秘的现象。
通过对上述实际案例我们可以看到,本发明提供的一种清调食补汤剂的配方,对于不同身体情况,会出现调整效果快慢的情况,本饮品缓慢调节人体机能,每日排出毒素,清理肠胃,最终达到增强身体免疫力,增强体质,并且简单实用,易操作,是一种适合现代人使用的保健饮品。
Claims (1)
1.本发明提供了一种清调食补饮品的配方,藏红花8-12枚、西洋参3-8g、枸杞5-10g、麦冬5-15g、陈皮3-8g、甘草3-8g、决明子5-10g、大枣5-10g、黄豆5-15g、红小豆5-10g、江米5-10g、薏米仁5-10g,黑米8-15g、玉米8-15g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510514665.9A CN106418015A (zh) | 2015-08-18 | 2015-08-18 | 一种清调食补饮品的配方和制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510514665.9A CN106418015A (zh) | 2015-08-18 | 2015-08-18 | 一种清调食补饮品的配方和制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106418015A true CN106418015A (zh) | 2017-02-22 |
Family
ID=58093920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510514665.9A Pending CN106418015A (zh) | 2015-08-18 | 2015-08-18 | 一种清调食补饮品的配方和制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106418015A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107440100A (zh) * | 2017-08-14 | 2017-12-08 | 孙士英 | 一种提高免疫力的保健汤剂及其制备方法 |
CN109907194A (zh) * | 2019-04-08 | 2019-06-21 | 刘秀芸 | 一种保健饮品的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1068040A (zh) * | 1992-06-29 | 1993-01-20 | 潘海滨 | 毓麟固本衫药芯配制工艺 |
CN1395966A (zh) * | 2002-08-23 | 2003-02-12 | 李冠祥 | 一种抗衰老中成药 |
CN101449773A (zh) * | 2007-11-28 | 2009-06-10 | 天津市中英保健食品有限公司 | 新型食疗粥及其生产工艺 |
CN101884422A (zh) * | 2010-06-07 | 2010-11-17 | 王春玲 | 多元素中药保健饮品 |
CN102861235A (zh) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | 一种纯中药养生制剂 |
CN103263608A (zh) * | 2013-05-14 | 2013-08-28 | 亳州市远光中药饮片厂 | 一种排毒养颜的中药原粉 |
-
2015
- 2015-08-18 CN CN201510514665.9A patent/CN106418015A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1068040A (zh) * | 1992-06-29 | 1993-01-20 | 潘海滨 | 毓麟固本衫药芯配制工艺 |
CN1395966A (zh) * | 2002-08-23 | 2003-02-12 | 李冠祥 | 一种抗衰老中成药 |
CN101449773A (zh) * | 2007-11-28 | 2009-06-10 | 天津市中英保健食品有限公司 | 新型食疗粥及其生产工艺 |
CN101884422A (zh) * | 2010-06-07 | 2010-11-17 | 王春玲 | 多元素中药保健饮品 |
CN102861235A (zh) * | 2012-09-24 | 2013-01-09 | 天津鑫瑞生物医药科技有限公司 | 一种纯中药养生制剂 |
CN103263608A (zh) * | 2013-05-14 | 2013-08-28 | 亳州市远光中药饮片厂 | 一种排毒养颜的中药原粉 |
Non-Patent Citations (1)
Title |
---|
徐鸿华等: "《实用中草药图谱(珍藏版)》", 30 June 2012, 广东科技出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107440100A (zh) * | 2017-08-14 | 2017-12-08 | 孙士英 | 一种提高免疫力的保健汤剂及其制备方法 |
CN109907194A (zh) * | 2019-04-08 | 2019-06-21 | 刘秀芸 | 一种保健饮品的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103263608B (zh) | 一种排毒养颜的中药原粉 | |
CN102068707B (zh) | 一种b超使用的中药助影剂及其制备方法 | |
CN101797326B (zh) | 一种治疗肠鸣腹泻的中药制剂及其制备方法 | |
CN102451363A (zh) | 中草药减肥茶 | |
CN104489516A (zh) | 提高肿瘤患者术后免疫功能的养生粥及制法 | |
CN106562413A (zh) | 一种提高免疫力膏滋及其制备方法 | |
CN105233100A (zh) | 一种治疗糖尿病的饮料及其制备方法 | |
CN105031517A (zh) | 一种降三高的铁皮石斛保健茶及其制备方法 | |
CN104958646A (zh) | 一种润肠通便的中药制剂及其制备方法 | |
CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
CN104940645A (zh) | 一种具有美容养颜功能的铁皮石斛中药组合物及其制剂 | |
CN104042891A (zh) | 缓解产妇大便秘结的中药组合物及其制备方法 | |
CN111184176A (zh) | 基于体质学说用于九种不同体质的速食型养生食品组合物 | |
CN107744112A (zh) | 一种延缓衰老祛斑益智黑色膳食纤维代餐食品 | |
CN106418015A (zh) | 一种清调食补饮品的配方和制备方法 | |
CN104115960A (zh) | 一种鲜芦根凉茶饮料 | |
CN110279773A (zh) | 一种气虚型体质补气健脾、益肾强志的中药组合物 | |
CN105559076B (zh) | 一种备孕期男性全营养药膳餐糊 | |
CN102526537A (zh) | 一种治疗高血糖的药物组合物 | |
CN106036384A (zh) | 一种适合糖尿病患者食用的养生粥及其制备方法 | |
CN106804794A (zh) | 一种具有减肥降脂通便功效的保健茶 | |
CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
CN104474342A (zh) | 一种适宜三高人群饮用的茶膏及其制备方法 | |
CN109674014A (zh) | 用于花茶卤的组合物及制作方法 | |
CN108967757A (zh) | 一种红枣生姜浓浆生产工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: Yan Xinhua Document name: the First Notification of an Office Action |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Yan Xinhua Document name: Notification that Application Deemed to be Withdrawn |
|
DD01 | Delivery of document by public notice | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170222 |
|
WD01 | Invention patent application deemed withdrawn after publication |